| Continuing operations | — | — |
| Net sales | 5,613a | 4,867a |
| Royalty income and fees | 78a | 77a |
| Other revenue | 461a | 308a |
| Revenue | 6,152a | 5,252a |
| Cost of sales | -1,752a | -1,707a |
| Gross profit | 4,400a | 3,545a |
| Marketing and selling expenses | -2,075a | -1,594a |
| Research and development expenses | -1,781a | -1,630a |
| General and administrative expenses | -272a | -230a |
| Other operating income/expenses (-) | 564a | 566a |
| Operating profit before impairment, restructuring and other income and expenses | 836a | 657a |
| Impairment of non-financial assets | -73a | -5a |
| Restructuring expenses | -25a | -13a |
| Other income/expenses (-) | 586a | -35a |
| Operating profit | 1,324a | 604a |
| Financial income | 39a | 47a |
| Financial expenses | -200a | -210a |
| Profit before income taxes | 1,163a | 441a |
| Income tax expense | -98a | -98a |
| Profit from continuing operations | 1,065a | 343a |
| Discontinued operations | — | — |
| Profit/loss (-) from discontinued operations | 0a | 0a |
| Profit | 1,065a | 343a |
| Attributable to | — | — |
| Equity holders of UCB SA | 1,065a | 343a |
| Non-controlling interests | 0a | 0a |